Chrystal Paulos to Mice, Transgenic
This is a "connection" page, showing publications Chrystal Paulos has written about Mice, Transgenic.
Connection Strength
0.322
-
Human CD26high T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistence. Nat Commun. 2017 12 06; 8(1):1961.
Score: 0.118
-
Molecular properties of gp100-reactive T-cell receptors drive the cytokine profile and antitumor efficacy of transgenic host T cells. Pigment Cell Melanoma Res. 2019 01; 32(1):68-78.
Score: 0.031
-
Lack of p53 Augments Antitumor Functions in Cytolytic T Cells. Cancer Res. 2016 09 15; 76(18):5229-5240.
Score: 0.027
-
IL-2Ra mediates temporal regulation of IL-2 signaling and enhances immunotherapy. Sci Transl Med. 2015 Oct 28; 7(311):311ra170.
Score: 0.025
-
Increased intensity lymphodepletion enhances tumor treatment efficacy of adoptively transferred tumor-specific T cells. J Immunother. 2010 Jan; 33(1):1-7.
Score: 0.017
-
Type 17 CD8+ T cells display enhanced antitumor immunity. Blood. 2009 Jul 16; 114(3):596-9.
Score: 0.016
-
Adoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriers. Blood. 2008 Dec 01; 112(12):4746-54.
Score: 0.016
-
Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood. 2008 Jul 15; 112(2):362-73.
Score: 0.015
-
IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy. Blood. 2008 Jun 01; 111(11):5326-33.
Score: 0.015
-
T-cell receptor gene therapy of established tumors in a murine melanoma model. J Immunother. 2008 Jan; 31(1):1-6.
Score: 0.015
-
Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD8 T cells. J Clin Invest. 2007 Feb; 117(2):492-501.
Score: 0.014
-
Interleukin-2-dependent mechanisms of tolerance and immunity in vivo. J Immunol. 2006 May 01; 176(9):5255-66.
Score: 0.013